153 related articles for article (PubMed ID: 7755388)
1. [The effect of combination treatment consisted of 5'-deoxy-5-fluorouridine and medroxyprogesterone acetate for recurrent breast cancer patient].
Toi M; Taniguchi T; Hayashi K; Tominaga T
Gan To Kagaku Ryoho; 1995 May; 22(6):799-804. PubMed ID: 7755388
[TBL] [Abstract][Full Text] [Related]
2. [Successful treatment of disseminated breast cancer with combination therapy of 5'-deoxy-5'-fluorouridine (5'-DFUR), medroxyprogesterone acetate (MPA) and cyclophosphamide (CPA)].
Takatsuka Y; Katoh T; Tsumura I; Kobayakawa K; Kawahara T
Gan To Kagaku Ryoho; 1992 Jan; 19(1):107-10. PubMed ID: 1530905
[TBL] [Abstract][Full Text] [Related]
3. [A case of breast cancer with lung and bone metastasis treated successfully by oral combination chemotherapy of 5'-deoxy-5-fluorouridine and cyclophosphamide].
Ishii K; Tsugawa K; Nakamura M; Ohnishi I; Miwa K
Gan To Kagaku Ryoho; 2003 Dec; 30(13):2133-6. PubMed ID: 14712778
[TBL] [Abstract][Full Text] [Related]
4. [A case of recurrent breast cancer responding to combination therapy with mitoxantrone (MIT), 5'-deoxy-5-fluorouridine (5'-DFUR) and medroxyprogesterone acetate (MPA)].
Kobayashi J; Kubota K; Ishikawa H; Asaumi S; Iwanami K; Matsumoto H; Kawashima K; Yokoe T; Iino Y; Morishita Y
Gan To Kagaku Ryoho; 1994 Oct; 21(14):2513-6. PubMed ID: 7944501
[TBL] [Abstract][Full Text] [Related]
5. [Results of tamoxifen-medroxyprogesterone acetate sequential therapy in 22 patients with recurrent breast cancer].
Noguchi S; Yamamoto H; Inaii H; Koyama H
Gan To Kagaku Ryoho; 1989 Nov; 16(11):3555-8. PubMed ID: 2530936
[TBL] [Abstract][Full Text] [Related]
6. [A patient with recurrent breast cancer whose liver metastasis regressed following combined use of weekly docetaxel and MPA.5'-DFUR].
Nakagomi H; Miyauchi Y; Okuda J; Muto S; Akaike H; Takahashi M; Mitui T; Ashizawa I; Chiba S; Nakazawa M; Imamura K
Gan To Kagaku Ryoho; 2001 Oct; 28(10):1431-5. PubMed ID: 11681252
[TBL] [Abstract][Full Text] [Related]
7. [Two cases of advanced breast cancer responding to oral chemoendocrine therapy with 5'-deoxy-5-fluorouridine, medroxyprogesterone acetate and cyclophosphamide (DMpC)].
Kihara M; Kontani K; Yamauchi A; Yokomise H
Gan To Kagaku Ryoho; 2005 May; 32(5):683-6. PubMed ID: 15918573
[TBL] [Abstract][Full Text] [Related]
8. [A case of long surviving advanced recurrent breast cancer with multiple bone metastases responding to treatment with 5'-DFUR combined with MPA].
Otsuka T; Terashima Y; Tashiro S
Gan To Kagaku Ryoho; 2002 Feb; 29(2):313-6. PubMed ID: 11865641
[TBL] [Abstract][Full Text] [Related]
9. [Chemotherapy with mitoxantrone for the treatment of recurrent breast cancer].
Matsuoka T; Nomizu T; Yabuta T; Katagata N; Watanabe F; Yamaki Y; Tsuchiya A; Takenoshita S
Gan To Kagaku Ryoho; 2000 Jul; 27(7):1051-5. PubMed ID: 10925694
[TBL] [Abstract][Full Text] [Related]
10. [Effective chemo-endocrine combination therapy for obstructive-jaundice caused by multiple liver metastasis of recurrent breast cancer--a case report].
Hoshino K; Nakamura M; Ikeda H; Koyama T; Morishita Y
Gan To Kagaku Ryoho; 1999 Jun; 26(7):983-7. PubMed ID: 10396328
[TBL] [Abstract][Full Text] [Related]
11. [A case of breast cancer with multiple organ metastases responding remarkably to combination therapy of CAF (cyclophosphamide, adriamycin and 5-FU), 5'-DFUR and MPA (medroxyprogesterone acetate)].
Maruyama S; Okumoto T; Kawasaki K; Ino H; Kanaya Y; Otani J; Yokoyama N; Soda M
Gan To Kagaku Ryoho; 2000 Dec; 27(14):2235-8. PubMed ID: 11142168
[TBL] [Abstract][Full Text] [Related]
12. [A case report of advanced breast cancer with remarkable response to chemoendocrine therapy (CTF + MPA)].
Yokota T; Fujii T; Roppongi T; Kanno K; Ogata T
Gan To Kagaku Ryoho; 1998 Apr; 25(5):739-42. PubMed ID: 9571973
[TBL] [Abstract][Full Text] [Related]
13. [A case of advanced recurrent breast cancer responding to treatment with weekly docetaxel combined with doxorubicin].
Sawada M; Ono Y; Fukushima M
Gan To Kagaku Ryoho; 2003 Feb; 30(2):259-62. PubMed ID: 12610876
[TBL] [Abstract][Full Text] [Related]
14. [The efficacy of combination chemotherapy of 5'-deoxy-5-fluorouridine (5'-DFUR), cyclophosphamide (CPA) and medroxyprogesterone acetate (MPA) for bone metastasis in breast cancer patients].
Iba T; Kidokoro A; Fukunaga M; Sugiyama K; Aihara N; Suda M
Gan To Kagaku Ryoho; 2001 Jul; 28(7):973-7. PubMed ID: 11478147
[TBL] [Abstract][Full Text] [Related]
15. [A case of postoperative recurrent breast cancer with multiple lung metastases that completely responded to combination therapy of docetaxel (TXT) and medroxyprogesterone acetate (MPA)].
Mio H
Gan To Kagaku Ryoho; 2003 Jul; 30(7):985-8. PubMed ID: 12894715
[TBL] [Abstract][Full Text] [Related]
16. The efficacy of long-term oral chemotherapy with 5'-deoxy-5-fluorouridine and cyclophosphamide for recurrent breast cancer.
Iba T; Kidokoro A; Fukunaga M; Sugiyama K; Aihara N; Suda M
Int J Clin Oncol; 2004 Oct; 9(5):383-7. PubMed ID: 15549589
[TBL] [Abstract][Full Text] [Related]
17. [5'-deoxy-5-fluorouridine (5'-DFUR), mitomycin C (MMC), etoposide and medroxy progesterone acetate (MPA) in a previously treated patient with advanced breast cancer].
Yoshinaka K; Yagi M; Ohtagaki S; Toi M; Toge T
Gan To Kagaku Ryoho; 1991 Jan; 18(1):115-8. PubMed ID: 1824814
[TBL] [Abstract][Full Text] [Related]
18. A phase II trial of mitomycin C, 5'-deoxy-5-fluorouridine, etoposide and medroxyprogesterone acetate (McVD-MPA) as a salvage chemotherapy to anthracycline-resistant tumor in relapsed breast cancer and its mechanism(s) of antitumor action.
Kim R; Osaki A; Tanabe K; Kojima J; Toge T
Oncol Rep; 2001; 8(3):597-603. PubMed ID: 11295087
[TBL] [Abstract][Full Text] [Related]
19. [Successful endocrine chemotherapy in patients with multiple bone metastases of breast cancer--a case report].
Tanaka R; Fukushima H; Sato K; Matsuda M; Hanaoka T; Goya T
Gan To Kagaku Ryoho; 1999 Oct; 26(11):1647-50. PubMed ID: 10553425
[TBL] [Abstract][Full Text] [Related]
20. [Advanced breast cancer with multiple bone metastases successfully treated with combined chemoendocrine-therapy of CEF (cyclophosphamide, epirubicin, 5-fluorouracil) and 5'-DFUR (5'-deoxy-5-fluorouridine) + MPA (medroxyprogesterone acetate)--a case report].
Fukuda Y; Hirao S; Koyama I; Takatori H; Terakura M; Mayumi K; Tsukazaki Y; Kinoshita H
Gan To Kagaku Ryoho; 2001 Feb; 28(2):217-20. PubMed ID: 11242649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
